To assess the absolute and comparative benefit and tolerability of pharmacological therapies for the treatment of central neuropathic pain syndromes in people with MS.
This is a protocol.
Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis
You may also be interested in:
- Pharmacological agents as symptomatic treatment for memory disorder in people with multiple sclerosis
- Treatment of seizures for patients with multiple sclerosis
- The effect of amantadine for the treatment of fatigue in people with multiple sclerosis
- The effect of anti-spasticity agents in people with multiple sclerosis
- The use of different treatment for incoordination of limb movement (ataxia) or tremor in people with multiple sclerosis
Health topics: